Kazakhstan vs Kuwait: Estimated antiretroviral therapy coverage among people living with HIV
Kazakhstan
79.0%
in 2025
Kuwait
80.0%
in 2025
Kazakhstan rank
57th
Kuwait rank
54th
Estimated antiretroviral therapy coverage among people living with HIV over time
- Kazakhstan
- Kuwait
How they compare
Kuwait currently reports 80.0% against 79.0% in Kazakhstan, a difference of 1.0%.
Across all 26 years both countries report, Kuwait has been ahead every year.
Kazakhstan ranks 57th and Kuwait ranks 54th of 143 countries.
Kuwait has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Kuwait | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.2% | 51.1% | 48.9% | Kuwait |
| 2010s | 26.0% | 65.4% | 39.4% | Kuwait |
| 2020s | 68.2% | 76.7% | 8.5% | Kuwait |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher estimated antiretroviral therapy coverage among people living with hiv, Kazakhstan or Kuwait?
- Kuwait, at 80.0% against 79.0% in Kazakhstan as of 2025.
- What is the difference in estimated antiretroviral therapy coverage among people living with hiv between Kazakhstan and Kuwait?
- 1.0%, with Kuwait ahead.
- How many years of comparable data are there for Kazakhstan and Kuwait?
- 26 years are reported by both, from 2000 to 2025.
- How do Kazakhstan and Kuwait rank globally for estimated antiretroviral therapy coverage among people living with hiv?
- Kazakhstan ranks 57th and Kuwait ranks 54th of 143 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.